LSBio
CDH2 / N Cadherin Antibody (Cytoplasmic Domain, clone 13A9)

HT1080 lysate probed with Mouse anti-Human N-cadherin followed by Rabbit F(ab')2 anti-Mouse IgG:HRP

CDH2 / N Cadherin Antibody (Cytoplasmic Domain, clone 13A9)

Primary AntibodyLSBio Guarantee
Antibody:Mouse Monoclonal
Applications:Immunofluorescence, Immunohistochemistry, Frozen, Immunohistochemistry, Paraffin, Immunoprecipitation, Western Blot
Reactivity:Human
Format:Liquid
See all Human CDH2 / N Cadherin antibodies →
$415.00each
Catalog Number: LS-C187536-0.2

For bulk orders or custom formulations:

Request a Quote

Overview

Description
N Cadherin antibody LS-C187536 is an unconjugated mouse monoclonal antibody to human N Cadherin (CDH2) (Cytoplasmic Domain). Validated for IF, IHC, IP and WB.
Application
IF, IHC-F, IHC-P, IP, WB
Reactivity
Hu
Intended Use
Research Use Only
Guarantees
This antibody carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Monoclonal Antibodies
Alternative Names
CDH2 | CDw325 | CDHN | Cadherin-2 | CD325 | CD325 antigen | N Cadherin | N-cadherin | NCAD | Neural cadherin | N-cadherin 1 | Neural-cadherin
Recommended Dilution: WB
1:100 - 1:1000
UniProt Number
P19022
SwissProt
P19022

Target

Target
Human CDH2 / N Cadherin
Antigen Species
Human
Epitope
Recognizes neural cadherin, otherwise known as CD325, a calcium dependent cell-cell adhesion glycoprotein, and member of the cadherin superfamily, which links to the actin cytoskeleton via catenins, and plays a role in cell-matrix adhesion, cell growth and differentiation, and the establishment of left-right asymmetry. N-cadherin is expressed by neurons, endothelial cells, muscle cells, and stem cells, and is one of the primary cadherins recruited to the site of neuronal synapse formation. N-cadherin is directly involved in the differentiation of early hematopoietic progenitors, and is commonly expressed by cancer cells, playing a role in transendothelial migration and metastasis, through the up-regulation of the src kinase pathway, and subsequent failure of the intercellular connection between two adjacent endothelial cells. Studies using clone 13A9 have demonstrated that expression levels of E-Cadherin and N-Cadherin have a role to play in the invasive properties of breast cancer. Decreased levels of E-cadherin and loss of E-cadherin-mediated adhesion, can result in the transition of a benign epithelial tumor to an invasive tumor, and increase invasiveness, whilst the expression of N-cadherin correlates with motility, invasiveness and tumor metastasis, irrespective of the presence of E-cadherin see for details. Clone 13A9 has been shown to be specific for N-cadherin, and does not recognize E-cadherin, M-cadherin or P-cadherin, see for details. Immunohistological studies have shown that clone 13A9 can be used as a reliable marker for the differential diagnosis of pleural mesotheliomas and lung adenocarcinomas, when used in conjunction with E-cadherin see for details.
Gene Name
CDH2

Antibody

Host Species
Mouse
Clonality
Monoclonal
Clone
13A9
Isotype
IgG1

Immunogen

Immunogen
Recombinant MBP fusion protein containing the entire cytoplasmic domain of human N-cadherin.
Immunogen Type
Fusion Protein (e.g., GST, MBP tag)

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
PBS, 0.09% Sodium Azide
Concentration
1 mg/mL
Preservative
Yes
Purification Method
Protein G Affinity

Storage & Handling

Storage Conditions
Store at 4°C or at -20°C. Store undiluted. Avoid freeze-thaw cycles. Microcentrifugation recommended if solution contains precipitate.
Recommended Storage Buffer
PBS

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.